These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12453936)

  • 1. Parkinson's disease and anaesthesia.
    Nicholson G; Pereira AC; Hall GM
    Br J Anaesth; 2002 Dec; 89(6):904-16. PubMed ID: 12453936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anaesthesia in patients with Parkinson's disease].
    Kalenka A; Hinkelbein J
    Anaesthesist; 2005 Apr; 54(4):401-9; quiz 410-1. PubMed ID: 15778805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaesthesia and Parkinson's disease: how to manage with new therapies?
    Kalenka A; Schwarz A
    Curr Opin Anaesthesiol; 2009 Jun; 22(3):419-424. PubMed ID: 19342948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [General anaesthesia for neurological diseases].
    Schneemilch C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 May; 45(5):336-44. PubMed ID: 20455190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations.
    Burton DA; Nicholson G; Hall GM
    Drugs Aging; 2004; 21(4):229-42. PubMed ID: 15012169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment challenges in Parkinson's disease.
    Welsh M
    Nurse Pract; 2008 Jul; 33(7):32-8. PubMed ID: 18600170
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C; Schumacher HC; Burgut FT
    Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of selective monoamine oxidase B inhibitors in the therapeutic strategy of Parkinson's disease in the neurology clinics of Tirgu Mures County Emergency Clinical Hospital].
    Szász JA; Constantin V; Fazakas PA; Blényesi E; Grieb LG; Balla A; Sárig M; Szegedi K; Bartha EN; Szatmári S
    Orv Hetil; 2017 Dec; 158(51):2023-2028. PubMed ID: 29250969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in treatment of Parkinson's disease].
    Narabayashi H
    Nihon Rinsho; 1990 Dec; 48(12):2943-50. PubMed ID: 2086859
    [No Abstract]   [Full Text] [Related]  

  • 11. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
    Chen JJ; Fernandez HH
    Drugs Aging; 2007; 24(8):663-80. PubMed ID: 17702535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent progress of therapy in patients with Parkinson's disease].
    Yanagisawa N
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1109-14. PubMed ID: 8228492
    [No Abstract]   [Full Text] [Related]  

  • 13. MAO-B inhibitors in Parkinson's disease.
    Olanow CW
    Adv Neurol; 1993; 60():666-71. PubMed ID: 8420207
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
    Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC
    Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peri-operative management of patients with Parkinson's disease.
    Yim RLH; Leung KMM; Poon CCM; Irwin MG
    Anaesthesia; 2022 Jan; 77 Suppl 1():123-133. PubMed ID: 35001381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaesthesia and Parkinson's disease].
    Chhor V; Karachi C; Bonnet AM; Puybasset L; Lescot T
    Ann Fr Anesth Reanim; 2011; 30(7-8):559-68. PubMed ID: 21530145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present strategy and future perspective of therapy in Parkinson's disease].
    Kuno S
    No To Shinkei; 1996 Jan; 48(1):18-25. PubMed ID: 8679314
    [No Abstract]   [Full Text] [Related]  

  • 19. Modes of drug delivery used to manage Parkinson's disease.
    Noble C
    Nurs Times; 2006 Aug 8-14; 102(32):30-2. PubMed ID: 16922099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease.
    Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS
    Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.